MitoTax s.r.o.
PrivateCompany Overview
MitoTax s.r.o. is a biotechnology company focused on the development of mitochondria-targeted cancer therapeutics, specifically the MitoTam intellectual property.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologycancer therapeuticsdrug discoverymitochondrial metabolismclinical trialsoncology researchbiotechdrug developmentanti-cancer agentintellectual propertypharma R&Dclinical-stage biotechdrug resistancebiomedical research
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MitoTax s.r.o. Comparables
Compare MitoTax s.r.o. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Morningside | 79% | |
| ImmunoMet Therapeutics | 78% | |
| Cryton Biosciences | 77% | |
MitoTax s.r.o. Funding Rounds
Historical fundraising activity
MitoTax s.r.o. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MitoTax s.r.o.'s valuation, stock price, and market status.
See something wrong or outdated?